p53 and p16INK4A independent induction of senescence by chromatin-dependent alteration of S-phase progression

被引:0
|
作者
Alexandre Prieur
Emilie Besnard
Amélie Babled
Jean-Marc Lemaitre
机构
[1] INSERM,
[2] Avenir Team 'Genome Plasticity and Aging',undefined
[3] –Functional Genomics Institute,undefined
[4] Centre Régional de Lutte contre le Cancer Val d'Aurelle-Paul Lamarque–208,undefined
[5] rue des Apothicaires,undefined
[6] Parc Euromédecine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Senescence is triggered by various cellular stresses that result in genomic lesions and DNA damage response activation. However, the role of chromatin and DNA replication in senescence induction remains elusive. Here we show that downregulation of p300 histone acetyltransferase activity induces senescence by a mechanism that is independent of the activation of p53, p21CIP1 and p16INK4A. This inhibition leads to a global H3, H4 hypoacetylation, initiating senescence-associated heterochromatic foci formation during S phase, together with a global decrease in replication fork velocity, and alteration of DNA replication timing. This replicative stress occurs without DNA damage and checkpoint activation, but results in a robust G2/M cell cycle arrest, within only one cell cycle. These results provide new insights into the control of S-phase progression by p300, and identify an unexpected chromatin-dependent alternative mechanism for senescence induction, which could possibly be exploited to treat cancer by senescence induction without generating further DNA damage.
引用
收藏
相关论文
共 50 条
  • [31] p53 and p16Ink4a constrain progression of pancreatic adenocarcinoma in the mouse:: Correlations between genotype and histologic phenotype
    Chu, GC
    Bardeesy, N
    Aguirre, AJ
    Redston, MS
    DePinho, RA
    MODERN PATHOLOGY, 2006, 19 : 271A - 271A
  • [32] P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia
    Güran, S
    Bahçe, M
    Beyan, C
    Korkmaz, K
    Yalçin, A
    HAEMATOLOGIA, 1998, 29 (03) : 181 - 193
  • [33] Hypermethylation-associated inactivation of p14ARF is independent of p16INK4a methylation and p53 mutational status
    Esteller, M
    Tortola, S
    Toyota, M
    Capella, G
    Peinado, MA
    Baylin, SB
    Herman, JG
    CANCER RESEARCH, 2000, 60 (01) : 129 - 133
  • [34] How is the mutational status for tumor suppressors p53 and p16INK4A in MFH of the bone?
    Taubert, H
    Berger, D
    Hinze, R
    Meye, A
    Würl, P
    Hogendoorn, PCW
    Holzhausen, HJ
    Schmidt, H
    Rath, FW
    CANCER LETTERS, 1998, 123 (02) : 147 - 151
  • [35] Clinical significance of p16INK4A and p53 overexpression in endocrine tumors of the gastrointestinal tract
    Li, Anna Fen-Yau
    Tsay, Shyh-Haw
    Liang, Wen-Yih
    Li, Wing-Yin
    Chen, Jeou-Yuan
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 126 (06) : 856 - 865
  • [36] Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias
    Nasser, Wasim
    Flechtenmacher, Christa
    Holzinger, Dana
    Hofele, Christof
    Bosch, Franz X.
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2011, 40 (08) : 629 - 635
  • [37] A simple stochastic model for the feedback circuit between p16INK4a and p53 mediated by p38MAPK: implications for senescence and apoptosis
    de Oliveira, L. R.
    Mombach, J. C. M.
    Castellani, G.
    MOLECULAR BIOSYSTEMS, 2015, 11 (11) : 2955 - 2963
  • [38] P16INK4a immunostaining and progression of LSIL to HSIL
    Davidson, C. M.
    Manduch, M.
    Behjati, R.
    Childs, T. J.
    MODERN PATHOLOGY, 2008, 21 : 201A - 201A
  • [39] P16INK4a immunostaining and progression of LSIL to HSIL
    Davidson, C. M.
    Manduch, M.
    Behjati, R.
    Childs, T. J.
    LABORATORY INVESTIGATION, 2008, 88 : 201A - 201A
  • [40] p16INK4a can initiate an autonomous senescence program
    Dai, CY
    Enders, GH
    ONCOGENE, 2000, 19 (13) : 1613 - 1622